5 Giant Healthcare Stocks With Large Institutional Ownership

Wall St. Watchdog reveals information on some large cap Healthcare companies whose shares are at least 25% owned by institutions:

  • Johnson + Johnson (NYSE:JNJ): Institutional investors own 64.17% of this company’s shares. The shares recently traded at $61.84 and its market capitalization is $169,512,300,000.00. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. Johnson & Johnson Earnings Cheat Sheet: Margins Shrink For Fifth Straight Quarter as Profit Falls>>
  • Pfizer Inc. (NYSE:PFE): Institutional investors own 73.10% of this company’s shares. The shares recently traded at $17.36 and its market capitalization is $137,163,600,000.00. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Merck + Co., Inc. (NYSE:MRK): Institutional investors own 73.36% of this company’s shares. The shares recently traded at $31.51 and its market capitalization is $97,258,290,000.00. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Abbott Laboratories (NYSE:ABT): Institutional investors own 64.83% of this company’s shares. The shares recently traded at $48.77 and its market capitalization is $75,802,380,000.00. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Amgen, Inc. (NASDAQ:AMGN): Institutional investors own 80.61% of this company’s shares. The shares recently traded at $51.56 and its market capitalization is $47,936,910,000.00. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter >>

More from The Cheat Sheet